Clonazepam and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clonazepam (clonazepam) and Repaglinide (repaglinide). Common drug interactions include muscular weakness among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Clonazepam and Repaglinide. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Clonazepam?

Clonazepam has active ingredients of clonazepam. It is often used in stress and anxiety. eHealthMe is studying from 146,270 Clonazepam users. Check the latest studies of Clonazepam.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

On Jul, 20, 2026

73 people who take Clonazepam and Repaglinide together, and have interactions are studied.

Clonazepam and Repaglinide drug interactions.

What are the common drug interactions of Clonazepam and Repaglinide, by gender? *:

female:

Muscular weakness (muscle weakness)
Abdominal pain upper
Anaphylactic reaction (serious allergic reaction)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthma
Blood sodium decreased
Breast cancer
Chest pain
Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
Depressed level of consciousness

male:

Drug ineffective
Metabolic syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease)
Chronic kidney disease
Sleep disorder
Renal failure (kidney dysfunction)
Type 2 diabetes mellitus
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Emotional distress
Fall
Gait disturbance

What are the common drug interactions of Clonazepam and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Sleep disorder
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Discomfort
Erythema (redness of the skin)
Pulmonary embolism (blockage of the main artery of the lung)
Rash
Rash papular (redness with papule)
Type 2 diabetes mellitus
Back pain

40-49:

Staphylococcus test positive
Urinary tract infection
Urinary tract infection enterococcal
Metabolic syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease)
Depressive symptom
Drug ineffective
Gynaecomastia (enlargement of the gland tissue of the male breast)
Hyperprolactinaemia (abnormally high levels of prolactin in the blood)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Pancreatitis acute (sudden inflammation of pancreas)

50-59:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Contusion (a type of hematoma of tissue in which capillaries)
Depression
Fall
Hypoaesthesia (reduced sense of touch or sensation)
Laceration (tearing of soft body tissue)
Pain in extremity
Somnolence (a state of near-sleep, a strong desire for sleep)
Urinary tract infection

60+:

Fall
Confusional state
Fatigue (feeling of tiredness)
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
Renal failure acute (rapid kidney dysfunction)
Gait disturbance
Hypotonia (low muscle tone)
Pain
Alopecia (absence of hair from areas of the body)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

High Blood Pressure: 22 people, 30.14%
Type 2 Diabetes: 13 people, 17.81%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 15.07%
Depression: 10 people, 13.70%
Pain: 9 people, 12.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 8 people, 10.96%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 10.96%
Urinary Tract Infection: 6 people, 8.22%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 8.22%
Hypertriglyceridaemia (excess of triglycerides in the blood): 6 people, 8.22%

* Approximation only. Some reports may have incomplete information.

Do you take Clonazepam and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously